The Group's principal activities are developing, designing and marketing radiation therapy systems used for the treatment of cancer. Products include the Super Gamma System (SGS), the Body Gamma Treatment System (BGTS), the Head Gamma Treatment System (HGTS) and a multileaf collimator device (MLC) used in conjunction with a linear accelerator. Products are sold directly to hospitals and to third party investors in China that install systems in hospitals. It is also engaged in offering comprehensive post-sales services for medical equipment to the customers. Post sales services include radioactive cobalt source replacement and disposal, training, product maintenance, software upgrades, and consulting. The Group operates in the People's Republic of China.
Alacra Alerts:
Receive alerts on the latest reports on Huiheng Medical Inc.
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
